Table 1.
Characteristics | Patients | % |
---|---|---|
Age, years | ||
Median | 69 | |
Range | 47–85 | |
Gender | ||
Male | 52 | 85.2 |
Female | 9 | 14.8 |
Race | ||
Caucasian | 54 | 88.5 |
Asian | 4 | 6.6 |
Black | 2 | 3.3 |
Arabic | 1 | 1.6 |
Histology | ||
Adenocarcinoma | 40 | 65.6 |
Squamous cell carcinoma | 18 | 29.5 |
Adenosquamous carcinoma | 1 | 1.6 |
Neuroendocrine carcinoma | 2 | 3.3 |
Primary site | ||
AEG1 | 26 | 42.6 |
AEG2 | 19 | 31.1 |
Esophagus | 16 | 26.2 |
Tumor grade | ||
Moderate | 31 | 50.8 |
Poor | 30 | 49.2 |
Baseline T stage | ||
T1 | 4 | 6.6 |
T2 | 7 | 11.5 |
T3 | 49 | 80.3 |
T4a | 1 | 1.6 |
Baseline N stage | ||
N0 | 26 | 42.6 |
N1 | 34 | 55.8 |
N2 | 1 | 1.6 |
Baseline stage | ||
IB | 2 | 3.3 |
IIA | 5 | 8.1 |
IIB | 22 | 36.1 |
IIIA | 27 | 44.3 |
IIIB | 4 | 6.6 |
IIIC | 1 | 1.6 |
AEG = Adenocarcinoma of the esophagogastric junction. |